An announcement from dorsaVi Limited ( (AU:DVL) ) is now available.
dorsaVi Limited has reported significant progress in the commercial release of its AI-powered Video Movement Analysis Platform, gaining traction in the US market. The company has achieved sales revenue of $289k and is advancing security clearances with a major US clinical group, which could expand its market presence. Additionally, dorsaVi has launched a pioneering 3D motion analysis test to address ACL injuries, potentially setting a new standard in sports medicine. A new research collaboration with a prominent US surgeon aims to optimize movement analysis for elite athletes, further reinforcing dorsaVi’s leadership in data security and injury prevention.
More about dorsaVi Limited
dorsaVi Limited is a company operating in the healthcare technology industry, specializing in movement analysis solutions. Their primary products include AI-powered video movement analysis platforms and wearable sensor technology, aimed at enhancing clinical assessments and injury prevention strategies. The company focuses on markets such as elite sports, clinical rehabilitation, and orthopaedic injury prevention.
Average Trading Volume: 63,500
Technical Sentiment Signal: Buy
Current Market Cap: A$5.12M
Find detailed analytics on DVL stock on TipRanks’ Stock Analysis page.